TY - JOUR
T1 - Rapid and reversible knockdown of endogenously tagged endosomal proteins via an optimized HaloPROTAC degrader
AU - Tovell, Hannah
AU - Testa, Andrea
AU - Maniaci, Chiara
AU - Zhou, Houjiang
AU - Prescott, Alan
AU - Macartney, Thomas
AU - Ciulli, Alessio
AU - Alessi, Dario
N1 - This work was supported by the Medical Research Council [grant number MC_UU_12016/2 (to D.R.A.)]; the European Research Council (ERC) under the European Union’s Seventh Framework Programme (FP7/2007–2013) as a Starting Grant to A.C. [grant agreement No. ERC–2012–StG–311460 DrugE3CRLs]; the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (Boehringer Ingelheim, GlaxoSmithKline, and Merck KGaA, to D.R.A.). H.T. is supported by an AstraZeneca BBSRC Studentship.
PY - 2019/5/17
Y1 - 2019/5/17
N2 - Inducing post-translational protein knockdown is an important approach to probe biology and validate drug targets. An efficient strategy to achieve this involves expression of a protein of interest fused to an exogenous tag, allowing tag-directed chemical degraders to mediate protein ubiquitylation and proteasomal degradation. Here, we combine improved HaloPROTAC degrader probes with CRISPR/Cas9 genome editing technology to trigger rapid degradation of endogenous target proteins. Our optimized probe, HaloPROTAC-E, a chloroalkane conjugate of high-affinity VHL binder VH298, induced reversible degradation of two endosomally localized proteins, SGK3 and VPS34, with a DC
50 of 3-10 nM. HaloPROTAC-E induced rapid (∼50% degradation after 30 min) and complete (D
max of ∼95% at 48 h) depletion of Halo-tagged SGK3, blocking downstream phosphorylation of the SGK3 substrate NDRG1. HaloPROTAC-E more potently induced greater steady state degradation of Halo tagged endogenous VPS34 than the previously reported HaloPROTAC3 compound. Quantitative global proteomics revealed that HaloPROTAC-E is remarkably selective inducing only degradation of the Halo tagged endogenous VPS34 complex (VPS34, VPS15, Beclin1, and ATG14) and no other proteins were significantly degraded. This study exemplifies the combination of HaloPROTACs with CRISPR/Cas9 endogenous protein tagging as a useful method to induce rapid and reversible degradation of endogenous proteins to interrogate their function.
AB - Inducing post-translational protein knockdown is an important approach to probe biology and validate drug targets. An efficient strategy to achieve this involves expression of a protein of interest fused to an exogenous tag, allowing tag-directed chemical degraders to mediate protein ubiquitylation and proteasomal degradation. Here, we combine improved HaloPROTAC degrader probes with CRISPR/Cas9 genome editing technology to trigger rapid degradation of endogenous target proteins. Our optimized probe, HaloPROTAC-E, a chloroalkane conjugate of high-affinity VHL binder VH298, induced reversible degradation of two endosomally localized proteins, SGK3 and VPS34, with a DC
50 of 3-10 nM. HaloPROTAC-E induced rapid (∼50% degradation after 30 min) and complete (D
max of ∼95% at 48 h) depletion of Halo-tagged SGK3, blocking downstream phosphorylation of the SGK3 substrate NDRG1. HaloPROTAC-E more potently induced greater steady state degradation of Halo tagged endogenous VPS34 than the previously reported HaloPROTAC3 compound. Quantitative global proteomics revealed that HaloPROTAC-E is remarkably selective inducing only degradation of the Halo tagged endogenous VPS34 complex (VPS34, VPS15, Beclin1, and ATG14) and no other proteins were significantly degraded. This study exemplifies the combination of HaloPROTACs with CRISPR/Cas9 endogenous protein tagging as a useful method to induce rapid and reversible degradation of endogenous proteins to interrogate their function.
UR - http://www.scopus.com/inward/record.url?scp=85065914620&partnerID=8YFLogxK
U2 - 10.1021/acschembio.8b01016
DO - 10.1021/acschembio.8b01016
M3 - Article
C2 - 30978004
SN - 1554-8929
VL - 14
SP - 882
EP - 892
JO - ACS Chemical Biology
JF - ACS Chemical Biology
IS - 5
ER -